On January 11th, Mark Zuckerberg announced some major changes to the way they will build Facebook. Moving forward, the focus will shift from helping users find relevant content to helping users have more "meaningful social interactions”. The change will affect various elements of the platform's user experience and products, starting with the News Feed.
2017 sure kept things interesting. In the fast-changing world of social, each platform has had dozens of updates over the past year. Just like last year, we’re here to review the most important social platform updates and highlight how they will shape social trends in the coming year. Several of the
This POV discusses Facebook’s policies on ads, how pharma will be affected, and how Intouch can help navigate new social media waters.
In early November, we published a POV written by Intouch Solutions social media manager, Andrew Grojean, about Twitter’s expanded character limit. Med Ad News reached out to Grojean and asked for a more in-depth version of the article, and he was pleased to provide it. What can you expect
“Dark social” sounds sinister and high-tech. Stealthy. Maybe even malevolent. What is this scary, villainous online activity? Calm down. Dark social is not evil. You’ve probably done it yourself just today. But it IS hiding the source of most of your traffic. Maybe as much as 75 percent. What is
Now that tweets can include up to 280 characters, what must pharma marketers keep in mind? This POV breaks it all down.
When you consider your social tactic mix, should you be looking at Snapchat and Tumblr? The answer may surprise you. As Medical Marketing & Media (MM&M) noted recently, “It may have taken longer than it did elsewhere, but pharma has finally achieved some not-insignificant degree of comfort and confidence
There are a variety of Facebook ad types that expand beyond just a static image. In this POV, we provide details on those ad types, including benefits and limitations.
This POV addresses why Facebook axed custom link previews, how the change impacts the posting process for pharma marketers, and what brands can do to continue to compliantly engage with users on the top social platform.
This POV explains the basics of Facebook targeting, some advanced options and new targeting opportunities beginning to roll out to advertisers.
